A5101306668- Cancer Immunotherapy and Biomarkers
- Immune Cell Function and Interaction
- Immune cells in cancer
- Hepatocellular Carcinoma Treatment and Prognosis
- Bladder and Urothelial Cancer Treatments
Beijing University of Chinese Medicine
2024
Background Neoadjuvant immunotherapy has demonstrated beneficial outcomes in various cancer types; however, standardized protocols for neoadjuvant hepatocellular carcinoma (HCC) are currently lacking. This systematic review and meta-analysis aims to investigate the reliability of immunotherapy’s efficacy safety context HCC. Methods A search was conducted across PubMed (MEDLINE), EMBASE, Web Science, Cochrane Library, conference proceedings identify clinical trials involving resectable HCC...
Malignant ascites is a common complication of advanced hepatocellular carcinoma (HCC) that seriously affects the quality life and survival patients has poor clinical efficacy. In early stages, authors found combination Shengqing Jiangzhuo decoction (SQJZD)and Endostar can effectively alleviate symptoms malignant in with HCC reduce amount ascites. The purpose this study was to investigate mechanism action SQJZD HCC-related A BALB/c mouse model established by intraperitoneal inoculation H22...
<i>Background </i>Breast nodules are a health issue that concerns women, and clinical practice entails great concern for accurate diagnosis appropriate prevention treatment. This study examined the correlation between ultrasound manifestations traditional Chinese medicine (TCM) syndrome differentiation of breast nodules. <i>Methods </i>This included 128 patients with based on ultrasound-dependent Breast Imaging-Reporting Data System...